Early high-dose rosuvastatin and cardioprotection in the protective effect of rosuvastatin and antiplatelet therapy on contrast-induced acute kidney injury and myocardial damage in patients with Acute Coronary Syndrome (PRATO-ACS) study

American Heart Journal

Volumn 168, Issue 5, 2014, Pages 792-797

  Leoncini, Mario ^a   Toso, Anna ^a,c   Maioli, Mauro ^a   Tropeano, Francesco ^a   Badia, Toni ^a   Villani, Simona ^b   Bellandi, Francesco ^a  

^a Prato Hospital   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c Santo Stefano Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; CREATINE KINASE MB; ROSUVASTATIN; TROPONIN I; CARDIOTONIC AGENT; CONTRAST MEDIUM; FLUOROBENZENE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PYRIMIDINE DERIVATIVE; SULFONAMIDE; TICLOPIDINE;

ACUTE CORONARY SYNDROME; ACUTE KIDNEY FAILURE; ANGIOGRAPHY; ANTICOAGULANT THERAPY; ARTICLE; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; CHEMICAL ANALYSIS; CONTRAST INDUCED ACUTE KIDNEY INJURY; CONTROLLED STUDY; DRUG EFFECT; DRUG MEGADOSE; HEART MUSCLE INJURY; HEART PROTECTION; HUMAN; MAJOR CLINICAL STUDY; PERCUTANEOUS CORONARY INTERVENTION; RANDOMIZED CONTROLLED TRIAL; ACUTE KIDNEY INJURY; ANALOGS AND DERIVATIVES; ANGIOCARDIOGRAPHY; BLOOD; CHEMICALLY INDUCED; HEART MUSCLE; METABOLISM; NECROSIS; PATHOLOGY; RADIOGRAPHY; TREATMENT OUTCOME;

ACUTE CORONARY SYNDROME; ACUTE KIDNEY INJURY; CARDIOTONIC AGENTS; CONTRAST MEDIA; CORONARY ANGIOGRAPHY; CREATINE KINASE, MB FORM; FLUOROBENZENES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MYOCARDIUM; NECROSIS; PERCUTANEOUS CORONARY INTERVENTION; PLATELET AGGREGATION INHIBITORS; PYRIMIDINES; SULFONAMIDES; TICLOPIDINE; TREATMENT OUTCOME; TROPONIN I;

EID: 84908344163     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2014.08.005     Document Type: Article

References (25)

1. M. Leoncini, A. Toso, and M. Maioli Early high-dose rosuvastatin for Contrast-Induced Nephropathy Prevention in Acute Coronary Syndrome. Results from Protective effect of Rosuvastatin and Antiplatelet Therapy On contrast-induced acute kidney injury and myocardial damage in patients with Acute Coronary Syndrome (PRATO-ACS Study) J Am Coll Cardiol 63 2014 71 79
2. R.T. Vollmer, R.H. Christenson, K. Reimer, and E.M. Ohman Temporal creatine kinase curves in acute myocardial infarction. Implications of a good empiric fit with the log-normal function Am J Clin Pathol 100 1993 293 298
3. K. Thygesen, J.S. Alpert, and A.S. Jaffe Third universal definition of myocardial infarction Circulation 126 2012 2020 2035
4. I.D. Moussa, L.W. Klein, and B. Shah Consideration of a new definition of clinically relevant myocardial infarction after coronary revascularization an expert consensus document from the Society for Cardiovascular Angiography and Interventions (SCAI) J Am Coll Cardiol 62 2013 1563 1570
5. C.M. Gibson, Y.B. Pride, and C.P. Hochberg Effect of intensive statin therapy on clinical outcomes among patients undergoing percutaneous coronary intervention for acute coronary syndrome PCI-PROVE IT: A PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) substudy J Am Coll Cardiol 54 2009 2290 2295
6. K.H. Yun, S.K. Oh, and S.J. Rhee 12-Month follow-up results of high dose rosuvastatin loading before percutaneous coronary intervention in patients with acute coronary syndrome Int J Cardiol 146 2011 68 72
7. G. Patti, C.P. Cannon, and S.A. Murphy Clinical benefit of statin pretreatment in patients undergoing percutaneous coronary intervention: a collaborative patient-level meta-analysis of 13 randomized studies Circulation 123 2011 1622 1632
8. A.M. Benjo, G.E. El-Hayek, and F. Messerli High dose statin loading prior to percutaneous coronary intervention decreases cardiovascular events: a meta-analysis of randomized controlled trials Catheter Cardiovasc Interv 2013 10.1002/ccd.25302
9. E.P. Navarese, K. Tandjung, and B. Claessen Meta-analysis of time-related benefits of statin therapy in patients with acute coronary syndrome undergoing percutaneous coronary intervention Am J Cardiol 113 2014 1753 1764
10. A.W. Chan, D.L. Bhatt, and D.P. Chew Early and sustained survival benefit associated with statin therapy at the time of percutaneous coronary intervention Circulation 105 2002 691 696
11. G. Patti, E. Ricottini, and A. Nusca Short-term, high-dose atorvastatin pretreatment to prevent contrast-induced nephropathy in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the ARMYDA-CIN [Atorvastatin for Reduction of MYocardial DAmage during angioplasty-Contrast-Induced Nephropathy] trial) Am J Cardiol 108 2011 1 7
12. C. Quintavalle, D. Fiore, and F. De Micco Impact of a high loading dose of atorvastatin on contrast-induced acute kidney injury Circulation 126 2012 3008 3016
13. Y. Han, G. Zhu, and L. Han Short-term rosuvastatin therapy for prevention of contrast-induced kidney injury in patients with diabetes and chronic kidney disease J Am Coll Cardiol 63 2014 62 70
14. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. The Platelet Receptor Inhibition in ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators N Engl J Med 338 1998 1488 1497 [Erratum in N Engl J Med 1998; 339: 415]
15. J.L. Januzzi, S.S. Hahn, and C.U. Chae Effects of tirofiban plus heparin versus heparin alone on troponin I levels in patients with acute coronary syndromes Am J Cardiol 86 2000 713 717
16. L. Wallentin, D. Lindholm, and A. Siegbahn PLATO study group. Biomarkers in relation to the effects of ticagrelor in comparison with clopidogrel in non-ST-elevation acute coronary syndrome patients managed with or without in-hospital revascularization: a substudy from the Prospective Randomized Platelet Inhibition and Patient Outcomes (PLATO) trial Circulation 129 2014 293 303
17. G. Patti, G. Bárczi, and D. Orlic Outcome comparison of 600- and 300-mg loading doses of clopidogrel in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: results from the ARMYDA-6 MI (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Myocardial Infarction) randomized study J Am Coll Cardiol 58 2011 1592 1599
18. F. Violi, C. Calvieri, D. Ferro, and P. Pignatelli Statins as antithrombotic drugs Circulation 127 2013 251 257
19. M. Piorkowski, S. Fischer, and C. Stellbaum Treatment with ezetimibe plus low-dose atorvastatin compared with higher-dose atorvastatin alone: is sufficient cholesterol-lowering enough to inhibit platelets? J Am Coll Cardiol 49 2007 1035 1042
20. C. Obi, W. Wysokinski, and K. Karnicki Inhibition of platelet-rich arterial thrombus in vivo. Acute antithrombotic effect of intravenous HMG-CoA reductase therapy Arterioscler Thromb Vasc Biol 29 2009 1271 1276
21. I. Müller, M. Seyfarth, and S. Rüdiger Effect of a high loading dose of clopidogrel on platelet function in patients undergoing coronary stent placement Heart 85 2001 92 93
22. T. Cuisset, C. Frere, and J. Quilici Benefit of a 600-mg loading dose of clopidogrel on platelet reactivity and clinical outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing coronary stenting J Am Coll Cardiol 48 2006 1339 1345
23. S.R. Mehta, J.F. Tanguay, and J.W. Eikelboom CURRENT-OASIS 7 trial investigators. Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial Lancet 376 2010 1233 1243
24. G. Patti, D. Grieco, and G. Dicuonzo High versus standard clopidogrel maintenance dose after percutaneous coronary intervention and effects on platelet inhibition, endothelial function, and inflammation results of the ARMYDA-150 mg (antiplatelet therapy for reduction of myocardial damage during angioplasty) randomized study J Am Coll Cardiol 57 2011 771 778
25. H. White Avatar of the universal definition of periprocedural myocardial infarction J Am Coll Cardiol 62 2013 1571 1574